Profound Medical (PROF) Revenue & Revenue Breakdown
Profound Medical Revenue Highlights
Latest Revenue (Y)
$10.68M
Latest Revenue (Q)
$2.62M
Main Segment (Y)
Recurring - Non-Capital
Main Geography (Y)
UNITED STATES
Profound Medical Revenue by Period
Profound Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $10.68M | 48.35% |
| 2023-12-31 | $7.20M | 7.75% |
| 2022-12-31 | $6.68M | -2.79% |
| 2021-12-31 | $6.87M | -5.90% |
| 2020-12-31 | $7.30M | 72.61% |
| 2019-12-31 | $4.23M | 121.48% |
| 2018-12-31 | $1.91M | -51.01% |
| 2017-12-31 | $3.90M | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | - |
Profound Medical generated $10.68M in revenue during NA 2024, up 48.35% compared to the previous quarter, and up 252.39% compared to the same period a year ago.
Profound Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $2.62M | -29.26% |
| 2024-12-31 | $3.71M | 30.83% |
| 2024-09-30 | $2.83M | 26.82% |
| 2024-06-30 | $2.23M | 16.91% |
| 2024-03-31 | $1.91M | -4.93% |
| 2023-12-31 | $2.01M | 16.26% |
| 2023-09-30 | $1.73M | 7.87% |
| 2023-06-30 | $1.60M | -13.87% |
| 2023-03-31 | $1.86M | 47.97% |
| 2022-12-31 | $1.26M | -38.23% |
| 2022-09-30 | $2.04M | 0.49% |
| 2022-06-30 | $2.02M | 48.46% |
| 2022-03-31 | $1.36M | 36.67% |
| 2021-12-31 | $998.00K | -60.66% |
| 2021-09-30 | $2.54M | -3.43% |
| 2021-06-30 | $2.63M | 269.48% |
| 2021-03-31 | $711.00K | -75.05% |
| 2020-12-31 | $2.85M | 27.98% |
| 2020-09-30 | $2.23M | 114.00% |
| 2020-06-30 | $1.04M | -5.41% |
| 2020-03-31 | $1.10M | -49.25% |
| 2019-12-31 | $2.17M | 320.63% |
| 2019-09-30 | $515.35K | 17.84% |
| 2019-06-30 | $437.32K | -60.43% |
| 2019-03-31 | $1.11M | -9.34% |
| 2018-12-31 | $1.22M | 418.72% |
| 2018-09-30 | $235.03K | 44.89% |
| 2018-06-30 | $162.21K | -44.34% |
| 2018-03-31 | $291.41K | -80.18% |
| 2017-12-31 | $1.47M | 24.49% |
| 2017-09-30 | $1.18M | 60.51% |
| 2017-06-30 | $735.94K | 65.92% |
| 2017-03-31 | $443.56K | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-03-31 | - | - |
Profound Medical generated $2.62M in revenue during Q1 2025, up -29.26% compared to the previous quarter, and up 130.46% compared to the same period a year ago.
Profound Medical Revenue Breakdown
Profound Medical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 22 | Dec 21 |
|---|---|---|---|
| Recurring - Non-Capital | $8.24M | - | - |
| Capital Equipment | $2.44M | - | - |
| Capital equipment | - | $2.00M | $3.15M |
| Recurring - non-capital | - | $4.68M | $3.29M |
Profound Medical's latest annual revenue breakdown by segment (product or service), as of Dec 24: Recurring - Non-Capital (77.15%), and Capital Equipment (22.85%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 |
|---|---|---|
| Recurring - Non-Capital | $1.56M | $1.80M |
| Capital Equipment | $650.00K | $820.00K |
Profound Medical's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Recurring - Non-Capital (70.60%), and Capital Equipment (29.40%).
Profound Medical Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| CALIFORNIA | $2.44M | - | - | - | - |
| DELAWARE | $891.00K | - | - | - | - |
| UNITED STATES | $7.35M | - | - | - | - |
| Germany | - | $1.80M | $1.43M | - | - |
| Canada | - | $1.49M | $1.72M | - | - |
| USA | - | $3.40M | $2.09M | - | - |
| C | - | - | - | $4.76M | $3.00M |
| D | - | - | - | $1.47M | $1.89M |
Profound Medical's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (68.82%), CALIFORNIA (22.84%), and DELAWARE (8.34%).
Quarterly Revenue by Country
| Country | Jun 25 | Mar 25 |
|---|---|---|
| GERMANY | $140.00K | - |
| CANADA | $570.00K | - |
| UNITED STATES | $1.98M | $1.54M |
| CALIFORNIA | - | $852.00K |
| DELAWARE | - | $226.00K |
Profound Medical's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (73.58%), CANADA (21.21%), and GERMANY (5.21%).
Profound Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SGHT | Sight Sciences | $79.87M | $17.51M |
| OWLT | Owlet | $78.10M | $21.10M |
| LNSR | LENSAR | $53.49M | $14.16M |
| RCEL | AVITA Medical | $50.56M | $18.51M |
| MXCT | MaxCyte | $38.63M | $10.39M |
| TLSI | TriSalus Life Sciences | $29.43M | $11.21M |
| RPID | Rapid Micro Biosystems | $28.05M | $7.26M |
| HYPR | Hyperfine | $12.89M | $2.14M |
| PROF | Profound Medical | $10.68M | $2.62M |
| AVR | Anteris Technologies Global | $2.73M | $556.00K |
| FBRX | Forte Biosciences | - | - |